Anebulo Pharmaceuticals Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Anebulo Pharmaceuticals in the last 12 months.

Price Target: n/a

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

According to 1 stock analyst, the rating for Anebulo Pharmaceuticals is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	1	0	0	0	0	0
Buy	1	1	1	1	1	0
Hold	0	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Okunewitch Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jul 23, 2025
Michael Okunewitch Maxim Group	Maxim Group	Strong Buy Maintains $6 → $3	Strong Buy	Maintains	$6 → $3	+28.21%	May 15, 2025
Robert Wasserman Benchmark	Benchmark	Buy Reiterates $8	Buy	Reiterates	$8	+241.88%	Nov 19, 2024
Robert Wasserman Benchmark	Benchmark	Buy Reiterates $8	Buy	Reiterates	$8	+241.88%	Oct 1, 2024
Robert Wasserman Benchmark	Benchmark	Buy Reiterates $8	Buy	Reiterates	$8	+241.88%	Oct 3, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.49

from -0.25

EPS Next Year

-0.47

from -0.49

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2028
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2028
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-2.83	-0.29	-0.47	-0.32	-0.25	-0.49	-0.47
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2028
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2028
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.50	-0.48
Avg	-0.49	-0.47
Low	-0.47	-0.45

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.